Yamaguchi S - Search Results

1

Clinical practice guideline for renal hypouricemia (1st edition).

Nakayama A, Matsuo H, Ohtahara A, Ogino K, Hakoda M, Hamada T, Hosoyamada M, Yamaguchi S, Hisatome I, Ichida K, Shinomiya N. Nakayama A, et al. Among authors: yamaguchi s. Hum Cell. 2019 Apr;32(2):83-87. doi: 10.1007/s13577-019-00239-3. Epub 2019 Feb 19. Hum Cell. 2019. PMID: 30783949 Free PMC article. Review.

2

Urinary excretion of uric acid, allantoin, and 8-OH-Deoxyguanosine in uricase-knockout mice.

Inazawa K, Yamaguchi S, Hosoyamada M, Fukuuchi T, Tomioka NH, Yamaoka N, Kaneko K. Inazawa K, et al. Among authors: yamaguchi s. Nucleosides Nucleotides Nucleic Acids. 2016 Dec;35(10-12):559-565. doi: 10.1080/15257770.2016.1163376. Nucleosides Nucleotides Nucleic Acids. 2016. PMID: 27906613

3

Proteomic analysis of a urinary stone with two layers composed of calcium oxalate monohydrate and uric acid.

Kaneko K, Kabeya M, Kondo H, Fukuuchi T, Yamaoka N, Yasuda M, Yamaguchi S. Kaneko K, et al. Among authors: yamaguchi s. Nucleosides Nucleotides Nucleic Acids. 2018;37(12):717-723. doi: 10.1080/15257770.2018.1478095. Epub 2018 Dec 27. Nucleosides Nucleotides Nucleic Acids. 2018. PMID: 30587091

4

Changes in Urinary Uric Acid Concentration after Dotinurad Administration to Patients with Hyperuricemia: A Post Hoc Analysis of Two Clinical Trials in Japan.

Takahashi T, Sasaki M, Shimizu T, Yamaguchi S. Takahashi T, et al. Among authors: yamaguchi s. Clin Pharmacol Drug Dev. 2024 Jan;13(1):87-95. doi: 10.1002/cpdd.1317. Epub 2023 Aug 9. Clin Pharmacol Drug Dev. 2024. PMID: 37559414

5

[Relationship between metabolic syndrome and urinary stone disease].

Yamaguchi S. Yamaguchi S. Clin Calcium. 2011 Oct;21(10):1489-95. Clin Calcium. 2011. PMID: 21960234 Review. Japanese.

6

Clinical outcomes for olfactory neuroblastoma.

Nakazono A, Motegi H, Suzuki M, Nakamaru Y, Yamaguchi S, Ishi Y, Kano S, Tsushima N, Honma A, Suzuki T, Kimura S, Hamada S, Taguchi J, Shimizu Y, Mori T, Yasuda K, Aoyama H, Kinoshita I, Fujimura M, Homma A. Nakazono A, et al. Among authors: yamaguchi s. Front Oncol. 2024 May 2;14:1329572. doi: 10.3389/fonc.2024.1329572. eCollection 2024. Front Oncol. 2024. PMID: 38756668 Free PMC article.

7

Oral bioavailability of a noncoding RNA drug, TY1, that acts on macrophages.

Yamaguchi S, Miyamoto K, Jones XM, Ciullo A, Morris A, Tsi K, Marbán E, Ibrahim AGE. Yamaguchi S, et al. bioRxiv [Preprint]. 2024 Apr 29:2024.04.27.591474. doi: 10.1101/2024.04.27.591474. bioRxiv. 2024. PMID: 38746093 Free PMC article. Preprint.

8

Development of a dose-rate dosimeter using a silicon photodiode for a medical linear accelerator in a 10 MV flattening filter-free mode.

Yamaguchi S, Ariga H, Yoshioka K. Yamaguchi S, et al. Rev Sci Instrum. 2024 May 1;95(5):053102. doi: 10.1063/5.0179656. Rev Sci Instrum. 2024. PMID: 38743570

9

High incidence of lung cancer death after curative endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.

Tajiri A, Tsujii Y, Nishida T, Inoue T, Maekawa A, Kitamura S, Yamaguchi S, Nishihara A, Yamada T, Ogiyama H, Murayama Y, Yamamoto S, Egawa S, Uema R, Yoshihara T, Hayashi Y, Takehara T. Tajiri A, et al. Among authors: yamaguchi s. Cancer Med. 2024 May;13(9):e7242. doi: 10.1002/cam4.7242. Cancer Med. 2024. PMID: 38733176 Free PMC article.

10

Bis-Ortho-Donor-Modification of Boracyclic π-Electron Systems beyond Steric Protection to Produce Thermally Activated Delayed Fluorescence Materials.

Narita H, Min H, Kubo N, Hattori I, Yasuda T, Yamaguchi S. Narita H, et al. Among authors: yamaguchi s. Angew Chem Int Ed Engl. 2024 May 7:e202405412. doi: 10.1002/anie.202405412. Online ahead of print. Angew Chem Int Ed Engl. 2024. PMID: 38714489

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,247 results

Search Page